P Littlejohns, K Chalkidou, AJ Culyer… - Journal of the Royal …, 2019 - journals.sagepub.com
On 1 April 2019, the National Institute for Health and Care Excellence was 20 years old. This is an anniversary worth noting, if for no other reason than how remarkable it is for a National …
S John - Studies in History and Philosophy of Science Part A, 2021 - Elsevier
Drawing on literature on values in science and a case-study of UK cancer policy, this paper argues for a novel account of the demarcation project in terms of trustworthiness. The first …
Background: Access to high-cost cancer drugs is an unsolved problem globally. The dedicated drugs fund is attractive and feasible. This study reviewed currently implemented …
EM Wood, DA Hughes - PharmacoEconomics, 2020 - Springer
The Cancer Drugs Fund (CDF) in England was established in 2011 to facilitate access to cancer medicines that were not routinely available on the National Health Service (NHS). By …
DJ Hunter, P Littlejohns - NICE at 25, 2025 - taylorfrancis.com
For the last 25 years the National Institute for Health and Care Excellence (NICE) has been a key part of the NHS. Despite numerous national re-organisations in which many …
N Wadd, C Peedell, C Polwart - Clinical Oncology, 2022 - Elsevier
Abstract Aims In England, not all cancer drugs are routinely funded; new medicines are first appraised by the National Institute for Health and Care Excellence. Funding can be …
P Littlejohns, A Knight, A Littlejohns… - … journal of health …, 2017 - Wiley Online Library
Abstract 2013 saw the National Health Service (NHS) in England severely criticized for providing poor quality despite successive governments in the previous 15 years …
A Mahalatchimy, A Faulkner - Regenerative medicine, 2017 - Taylor & Francis
Aim: This paper aims to map the trends and analyze key institutional dynamics that constitute the policies for reimbursement of regenerative medicine (RM), especially in the …